Concepedia

Mark Nuijten

MN

Statistics

Publications

46

Citations

1.8K

H-Index

25

Active since

1995

Affiliations

Erasmus University Rotterdam(Current)

Netherlands Leprosy Relief

Danone (France)

Abbott (Germany)

Shell (Netherlands)

Mark Nuijten is an author at Erasmus University Rotterdam specializing in cost-effectiveness analysis, pharmacy, and pharmacoeconomics.

Publications per year

1995–2022

46

Publications

46

The economic costs of disease related malnutrition

Karen Freijer, Siok Swan Tan, Marc Koopmanschap et al. · Clinical Nutrition · 2012 · 229 citations · Full text

Pharmacy, Economics, Pharmacoeconomics +12

Cost Effectiveness of Palivizumab for Respiratory Syncytial Virus Prophylaxis in High-Risk Children

Mark Nuijten, W Wittenberg, M. Lebmeier · PharmacoEconomics · 2007 · 99 citations

Pharmacy, Infectious Diseases, Pediatrics +16

Primary prevention of nephrolithiasis is cost‐effective for a national healthcare system

Yair Lotan, Inmaculada Buendía Jiménez, Irene Lenoir‐Wijnkoop et al. · British Journal of Urology · 2012 · 85 citations

Medicine, Nephrology, Urology +11

Importance of nondrug costs of intravenous antibiotic therapy

Arthur R. H. van Zanten, Peter Engelfriet, Karin van Dillen et al. · Critical Care · 2003 · 81 citations · Full text

Pharmacy, Internal Medicine, Pharmacoeconomics +16

Pricing Zolgensma – the world’s most expensive drug

Mark Nuijten · Journal of Market Access & Health Policy · 2021 · 79 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

1–5 of 46